首页 › 基金 › Orland Properties Ltd › LYEL
Orland Properties Ltd 对 LYEL 的持仓历史
LYELL IMMUNOPHARMA INC · 医疗保健
Orland Properties Ltd 在 Q3 2026 的 13F 申报中披露持有 LYEL(LYELL IMMUNOPHARMA INC)754,698 股,市值约 US$7.4M,约占其申报组合的 4.97%,在其申报持仓中市值排名第 3 位。 Orland Properties Ltd 最近 13 个申报季度中有 13 个季度披露了 LYEL 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR
Orland Properties Ltd 对 LYEL 的持仓演变
Orland Properties Ltd 于 Q3 2023 首次披露 LYEL 持仓:15,093,969 股(约 US$22.2M)。 该持仓在 Q1 2024 达到峰值 15,093,969 股,市值约 US$33.7M。 在 13 次申报中,Orland Properties Ltd 0 次增持、1 次减持、11 次保持不变。 最近一期申报(Q3 2026)显示持股 754,698 股、市值约 US$7.4M。 持仓曾出现大幅变动:Q2 2025 减持约 95% (随后一个季度股价上涨 84%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 15.09M | $22.19M | 新进 |
| Q4 2023 | 15.09M | $29.28M | 持有 |
| Q1 2024 | 15.09M | $33.66M | 持有 |
| Q2 2024 | 15.09M | $21.89M | 持有 |
| Q3 2024 | 15.09M | $20.83M | 持有 |
| Q4 2024 | 15.09M | $9.66M | 持有 |
| Q1 2025 | 15.09M | $8.15M | 持有 |
| Q2 2025 | 754.70K | $6.67M | 减持 |
| Q3 2025 | 754.70K | $12.26M | 持有 |
| Q4 2025 | 754.70K | $23.23M | 持有 |
| Q1 2026 | 754.70K | $15.14M | 持有 |
| Q2 2026 | 754.70K | $10.60M | 持有 |
| Q3 2026 | 754.70K | $7.39M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 LYEL 与 13F 数据
LYEL(LYELL IMMUNOPHARMA INC)属于医疗保健行业。我们追踪的基金中还有 28 只申报持有 LYEL,申报仓位最大的包括:ARCH Venture Management, LLC (US$45.5M), GSK plc (US$14.8M), Decheng Capital LLC (US$9.7M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 LYEL 的基金
- ARCH Venture Management, LLC 3.25M 股 · $45.53M · Q2 2026
- GSK plc 1.51M 股 · $14.81M · Q3 2026
- Decheng Capital LLC 692.05K 股 · $9.72M · Q2 2026
- Almitas Capital LLC 581.41K 股 · $8.17M · Q2 2026
- Foresite Capital Management V, LLC 476.39K 股 · $6.69M · Q2 2026
- Opaleye Management Inc. 344.02K 股 · $4.83M · Q2 2026
- venBio Partners LLC 337.70K 股 · $4.74M · Q2 2026
- Alphabet Inc. 293.26K 股 · $2.87M · Q3 2026
- HSG Holding Ltd 152.30K 股 · $1.49M · Q3 2026
- Velan Capital Investment Management LP 105.00K 股 · $1.48M · Q2 2026
- MIC Capital Management UK LLP 87.03K 股 · $1.22M · Q2 2026
更多关于 Orland Properties Ltd
常见问题
How long has Orland Properties Ltd held LYEL?
Orland Properties Ltd has disclosed LYEL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Orland Properties Ltd's current position in LYEL?
As of Q3 2026, Orland Properties Ltd holds 754.70K shares of LYEL (LYELL IMMUNOPHARMA INC), valued at $7.39M, representing 4.97% of its reported portfolio and ranking #3.
Has Orland Properties Ltd been buying or selling LYEL?
In the latest 13F filing (Q3 2026), Orland Properties Ltd held unchanged its position in LYEL. The position peaked in Q1 2024 at 15.09M shares.
Which other funds hold LYEL?
Other major institutional holders of LYEL include ARCH Venture Management, LLC, GSK plc, Decheng Capital LLC, among 28 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.